Nuvectis Pharma Stock Quote NVCT - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

5.5304

Bid

5.44

Ask

5.54

Volume

1,592,260

4.90 Day's Range 6.55

4.90 52 Week Range 12.10

Market Cap

106.853M

Previous Close

10.67

Open

5.09

Last Trade

5.44

Last Trade Time

15:23:36

Financial Volume

$ 9,327,849

VWAP

5.8582

Average Volume (3m)

140,300

Shares Outstanding

19,320,973

Dividend Yield

PE Ratio

-4.93

Earnings Per Share (EPS)

-1.15

Revenue

Net Profit

-22.26M

Nuvectis Pharma Inc is a biopharmaceutical company. Nuvectis Pharma Inc is a biopharmaceutical company.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.nuvectis.com

Headquarters

Wilmington, Delaware, USA

Founded

Nuvectis Pharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker NVCT. The last closing price for Nuvectis Pharma was $10.67. Over the last year, Nuvectis Pharma shares have traded in a share price range of $ 4.90 to $ 12.10.

Nuvectis Pharma currently has 19,320,973 shares outstanding. The market capitalization of Nuvectis Pharma is $206.15 million. Nuvectis Pharma has a price to earnings ratio (PE ratio) of -4.93.

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

PESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data Update

Nuvectis Pharma (NASDAQ: NVCT) continues to make strides in precision oncology, gaining momentum following presentations last week at the AACR-NCI-EORTC Symposium where its drug candidate NXP900...

PESG Releases Report on Nuvectis Pharma: With Summit Therapeutics Threatening to Dethrone Merck's Keytruda, Nuvectis' NXP900 is One to Watch

With its focus on targeting well-defined subgroups by inhibiting SRC/YES1 kinases in Non Small-Cell Lung Cancer patients resistant to EGFR and ALK targeted therapies, Nuvectis Pharma’s NXP900...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-2.699576	-32.8016524909	8.23	11.8	4.9	329244	10.3467833	CS
4	-1.099576	-16.5848567119	6.63	11.8	4.9	229504	8.7245191	CS
12	-1.659576	-23.0817246175	7.19	11.8	4.9	140300	7.74510581	CS
26	-0.829576	-13.0436477987	6.36	11.8	4.9	107756	7.29849369	CS
52	-2.889576	-34.3180047506	8.42	12.1	4.9	96801	7.69937859	CS
156	1.580424	40.0107341772	3.95	20.92	3.08	189034	7.94908227	CS
260	1.580424	40.0107341772	3.95	20.92	3.08	189034	7.94908227	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MTEMMolecular Templates Inc	$ 0.6872 (113.35%)	315.3M
XFORX4 Pharmaceuticals Inc	$ 0.458 (65.16%)	39.13M
QUBTQuantum Computing Inc	$ 4.155 (56.20%)	215.48M
ADGMAdagio Medical Holdings Inc	$ 3.62 (54.04%)	1.68M
OMEROmeros Corporation	$ 6.30 (50.36%)	12.62M
SOWGSow Good Inc	$ 4.27 (-56.47%)	2.61M
WCTWellchange Holdings Company Limited	$ 4.0713 (-48.46%)	1.14M
NVCTNuvectis Pharma Inc	$ 5.53 (-48.17%)	1.58M
TRNRInteractive Strength Inc	$ 3.6201 (-37.91%)	1.18M
MFHMercurity Fintech Holding Inc	$ 3.52 (-35.41%)	345.27k
ELABElevai Labs Inc	$ 0.0263 (6.48%)	1.69B
XTIAXTI Aerospace Inc	$ 0.0601 (5.07%)	339.68M
MTEMMolecular Templates Inc	$ 0.6872 (113.35%)	315.3M
SVMHSRIVARU Holding Ltd	$ 0.028 (15.70%)	238.2M
QUBTQuantum Computing Inc	$ 4.155 (56.20%)	215.48M